Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of 18F-FDG-PET for Staging and Prognostication in Patients Enrolled in the Fondazione Italiana Linfomi (FIL) MCL0208 Trial

NCT04600804 is registered in ClinicalTrials.gov with Fondazione Italiana Linfomi - ETS as lead sponsor.

NCT NCT04600804
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04600804 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of 18F-FDG-PET for Staging and Prognostication in Patients Enrolled in the Fondazione Italiana Linfomi (FIL) MCL0208 Trial
Lead sponsor
Fondazione Italiana Linfomi - ETS
Phase
Observational
Overall status
Completed
Start date
October 30, 2020
Completion date
July 11, 2025
Enrollment
200 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

mantle cell lymphoma